These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11055629)

  • 21. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma.
    Kuper H; Tzonou A; Kaklamani E; Hsieh CC; Lagiou P; Adami HO; Trichopoulos D; Stuver SO
    Int J Cancer; 2000 Feb; 85(4):498-502. PubMed ID: 10699921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.
    Franceschi S; Montella M; Polesel J; La Vecchia C; Crispo A; Dal Maso L; Casarin P; Izzo F; Tommasi LG; Chemin I; Trépo C; Crovatto M; Talamini R
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):683-9. PubMed ID: 16614109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
    Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
    Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
    Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
    J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
    Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
    Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma.
    Hadziyannis S; Tabor E; Kaklamani E; Tzonou A; Stuver S; Tassopoulos N; Mueller N; Trichopoulos D
    Int J Cancer; 1995 Mar; 60(5):627-31. PubMed ID: 7860136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma.
    Trichopoulos D; Day NE; Kaklamani E; Tzonou A; Muñoz N; Zavitsanos X; Koumantaki Y; Trichopoulou A
    Int J Cancer; 1987 Jan; 39(1):45-9. PubMed ID: 3025110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: possible role of alcohol in promoting carcinogenesis.
    Matsuda Y; Amuro Y; Higashino K; Hada T; Yamamoto T; Fujikura M; Yamaguchi K; Shimomura S; Iijima H; Nakano T
    Hepatogastroenterology; 1995 Apr; 42(2):151-4. PubMed ID: 7545640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why is hepatocellular carcinoma less attributable to viral hepatitis in Yemen?
    Saeed NM; Bawazir AA; Al-Zuraiqi M; Al-Negri F; Yunus F
    Asian Pac J Cancer Prev; 2012; 13(8):3663-7. PubMed ID: 23098451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aflatoxin B
    Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ
    Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
    Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
    J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma.
    Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
    J Med Virol; 1994 Sep; 44(1):92-5. PubMed ID: 7528262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
    Jiang MD
    Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B and C virus and hepatocellular carcinoma.
    Olubuyide IO; Aliyu B; Olalelye OA; Ola SO; Olawuyi F; Malabu UH; Odemuyiwa SO; Odaibo GN; Cook GC
    Trans R Soc Trop Med Hyg; 1997; 91(1):38-41. PubMed ID: 9093625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.